HMGB3 and esophageal squamous cell carcinoma: Previous studies showed that HMGB3 is implicated in the development of esophageal squamous cell cancer (ESCC), leukemia, gastric cancer (GC), urinary bladder cancer and non-small cell lung cancer (NSCLC) [25–29].